COMPANY OVERVIEW

Clarity Pharmaceuticals is a personalised medicine company focused on the treatment of serious diseases. The Company is a leader in innovative radiopharmaceuticals, developing targeted therapies for the treatment of cancer and other serious diseases in adults and children.

---

LOCATION

Sydney, , Australia

Montreal, Quebec, Canada

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://www.claritypharmaceuticals.com

---

CAREER WEBSITE

https://www.claritypharmaceuticals.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

May 25, 2021

NorthStar Medical Radioisotopes Enters U.S. Supply Agreement for Commercial Supply of Therapeutic Radioisotope Copper-67 (Cu-67) Exclusively to Clarity Pharmaceuticals for Its Targeted Copper Theranostics Programs

May 11, 2021

Shaemus Gleason Appointed Executive Vice President US Operations at Clarity Pharmaceuticals

Dec 15, 2020

Clarity Pharmaceuticals closes $25m capital raising

Sep 9, 2020

Clarity Pharmaceuticals Announces the US FDA Grants Rare Paediatric Disease Designation to 64Cu-SARTATE™, a diagnostic for the clinical management of neuroblastoma

Jul 23, 2020

Clarity Pharmaceuticals opens SARTATE neuroblastoma clinical trial

For More Press Releases

---